Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
The empagliflozin group achieved a mean weight loss of 3.6 kg and 3.8 kg in the two analyses, respectively
GLP-1 effects in certain areas of the brain ultimately lead to weight loss, and in addition to the cardioprotective and renoprotective effects discussed in this article, evidence also points towards neuroprotective and other medically desirable properties ( FIGURE 1 Currently, two main classes of GLP-1 RAs are available ( In accordance with their mechanism of action, all marketed GLP-1 RAs are indicated to improve glycaemic control in people with type 2 diabetes ( Epidemiology and pathophysiology of heart failure As one of the most prevalent consequences of CVD and other cardiometabolic conditions such as diabetes and hypertension, HF remains associated with high mortality rates ( As outlined earlier, cardiometabolic diseases or risk factors such as type 2 diabetes (ClinicalTrials.gov IDs NCT04916470 and NCT04788511), it may be relevant to consider obesity-related HFpEF as a specific (sub)phenotype, whether coexisting with type 2 diabetes or not
CNG DNG
Online, theres a booming peptide gray market. People are: Ordering research peptides online Mixing and self-injecting at home Sharing protocols on Reddit and TikTok Thats risky
Its driving that cardiovascular-renal-metabolic system where we all start working interdisciplinary and figuring out the answers together, rather than working in siloes
